Taysha Gene Therapies, Inc.
US ˙ NasdaqGS ˙ US8776191061

SecurityTSHA / Taysha Gene Therapies, Inc.
InsiderKamran Alam
This page shows the track record and history of Alam Kamran insider trades in Taysha Gene Therapies, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Kamran Alam in TSHA / Taysha Gene Therapies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TSHA / Taysha Gene Therapies, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Kamran Alam in TSHA / Taysha Gene Therapies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-08-21 54,491 2.8500 54,491 2.8500 155,299 7 2.8300 -1,089 -0.70

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TSHA / Taysha Gene Therapies, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-08-22 2025-08-21 4 Alam Kamran TSHA Common Stock S - Sale D 2.8500 -54,491 -155 1,187,603
2025-03-13 2025-03-11 4 Alam Kamran TSHA Common Stock F - Taxes D 1.6900 -29,843 -50 1,242,094
2025-01-03 2025-01-02 4 Alam Kamran TSHA Common Stock A - Award D 431,000 1,271,937
2024-02-06 2024-02-02 4 Alam Kamran TSHA Common Stock F - Taxes D 1.5100 -1,288 -2 840,937
2024-01-04 2024-01-02 4 Alam Kamran TSHA Common Stock A - Award D 590,413 842,225
2023-08-25 2023-08-24 4 Alam Kamran TSHA Common Stock S - Sale D 2.3300 -33,000 -77 258,042
2023-06-02 2023-05-31 4 Alam Kamran TSHA Common Stock A - Award D 6,230 291,042
2023-02-06 2023-02-02 4 Alam Kamran TSHA Common Stock A - Award D 18,691 284,812
2022-08-24 2022-08-23 4 Alam Kamran TSHA Common Stock S - Sale D 3.4700 -3,325 -12 266,121
2022-08-22 2022-08-22 4 Alam Kamran TSHA Common Stock S - Sale D 3.5000 -9,717 -34 269,446
2022-08-22 2022-08-19 4 Alam Kamran TSHA Common Stock S - Sale D 3.7500 -11,482 -43 279,163
2022-08-22 2022-08-18 4 Alam Kamran TSHA Common Stock S - Sale D 3.8700 -7,476 -29 290,645
2022-04-08 2022-04-06 4 Alam Kamran TSHA Employee Stock Option (right to buy) A - Award D 6.52 40,000 40,000
2022-02-25 2022-02-23 4 Alam Kamran TSHA Employee Stock Option (right to buy) A - Award D 5.96 80,000 80,000
2021-08-20 2021-08-20 4 Alam Kamran TSHA Common Stock S - Sale D 17.1400 -2,094 -36 298,121
2021-08-20 2021-08-20 4 Alam Kamran TSHA Common Stock S - Sale D 16.7000 -9,746 -163 300,215
2021-08-20 2021-08-19 4 Alam Kamran TSHA Common Stock S - Sale D 17.1100 -613 -10 309,961
2021-08-20 2021-08-19 4 Alam Kamran TSHA Common Stock S - Sale D 16.4300 -9,354 -154 310,574
2021-08-20 2021-08-18 4 Alam Kamran TSHA Common Stock S - Sale D 17.3500 -11,193 -194 319,928
2021-01-20 2021-01-19 4 Alam Kamran TSHA Stock Option (Right to Buy) A - Award D 31.00 70,000 70,000
2020-09-25 2020-09-23 4 Alam Kamran TSHA Common Stock A - Award D 331,121 331,121
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)